Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Juliane Schnalke"'
Autor:
Tobias Raphael Overbeck, Annika Reiffert, Katja Schmitz, Achim Rittmeyer, Wolfgang Körber, Sara Hugo, Juliane Schnalke, Laura Lukat, Tabea Hugo, Marc Hinterthaner, Kirsten Reuter-Jessen, Hans-Ulrich Schildhaus
Publikováno v:
Cancers, Vol 15, Iss 11, p 2966 (2023)
(1) Background: The main objectives of our study are (i) to determine the prevalence of NTRK (neurotrophic tyrosine kinase) fusions in a routine diagnostic setting in NSCLC (non-small cell lung cancer) and (ii) to investigate the feasibility of scree
Externí odkaz:
https://doaj.org/article/49345250d629498fa0182adab8e33929
Autor:
Kirsten Reuter-Jessen, Tessa Rosenthal, Laura Lukat, Annalen Bleckmann, Sara Hugo, Katja Schmitz, Achim Rittmeyer, Juliane Schnalke, Hans-Ulrich Schildhaus, Marc Hinterthaner, Wolfgang Körber, Dana Alina Cron, Joachim Moecks, Tabea Hugo, Tobias Overbeck
Publikováno v:
Translational Lung Cancer Research. 9:603-616
Ca Schildhaus Background: MET amplifications occur in human tumors, including non-small cell lung cancer (NSCLC). MET inhibitors have demonstrated some clinical activity in MET amplified NSCLC, presumably with a gene dose effect. However, the definit
Autor:
Tobias Raphael, Overbeck, Dana Alina, Cron, Katja, Schmitz, Achim, Rittmeyer, Wolfgang, Körber, Sara, Hugo, Juliane, Schnalke, Laura, Lukat, Tabea, Hugo, Marc, Hinterthaner, Kirsten, Reuter-Jessen, Tessa, Rosenthal, Joachim, Moecks, Annalen, Bleckmann, Hans-Ulrich, Schildhaus
Publikováno v:
Transl Lung Cancer Res
BACKGROUND: MET amplifications occur in human tumors, including non-small cell lung cancer (NSCLC). MET inhibitors have demonstrated some clinical activity in MET amplified NSCLC, presumably with a gene dose effect. However, the definition of MET pos